Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo
  1. Home

Boehringer Ingelheim’s obesity drug helps lose fat rather than muscle, late-stage trial shows

  • Posted on April 28, 2026
  • By Bing News
  • 0 Views
  • 1 min read
Boehringer Ingelheim’s obesity drug helps lose fat rather than muscle, late-stage trial shows
Boehringer Ingelheim’s obesity drug helps lose fat rather than muscle, late-stage trial shows

EXCLUSIVE: Survodutide shows potential to predominantly target visceral fat, its Chief Executive Shashank Deshpande said in an interview.
continue reading...

Author
Bing News

You May Also Like